CFDRX
Price
$15.93
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VMVAX
Price
$88.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

CFDRX vs VMVAX

Header iconCFDRX vs VMVAX Comparison
Open Charts CFDRX vs VMVAXBanner chart's image
Columbia Select Mid Cap Value Adv
Price$15.93
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$88.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
CFDRX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFDRX vs. VMVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFDRX is a StrongBuy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. CFDRX (2.68B). VMVAX pays higher dividends than CFDRX: VMVAX (2.14) vs CFDRX (0.95). CFDRX was incepted earlier than VMVAX: CFDRX (12 years) vs VMVAX (13 years). CFDRX is a more actively managed with annual turnover of: 30.00 vs. VMVAX (22.00). CFDRX has a lower initial minimum investment than VMVAX: CFDRX (2000) vs VMVAX (3000). CFDRX (29.65) and VMVAX (28.30) have marching annual gain over last year. VMVAX return over 5 years is better than : 48.86 vs. CFDRX (41.62).
CFDRXVMVAXCFDRX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD17.88518.47697%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets2.68B30.9B9%
Annual Yield % from dividends0.952.1444%
Returns for 1 year29.6528.30105%
Returns for 3 years6.8514.9846%
Returns for 5 years41.6248.8685%
Returns for 10 years-10.35100.72-10%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U19.13-0.09
-0.47%
Unity Software
MP19.12-0.73
-3.68%
MP Materials Corp
MLAB107.79-4.62
-4.11%
Mesa Laboratories
TTNP4.15-0.26
-6.00%
Titan Pharmaceuticals
LPTX2.99-0.25
-7.85%
Leap Therapeutics